Cadila Healthcare has declared the first day launch of Zolmitriptan
orally disintegrating tablets upon receiving the final approval from the
US Food and Drug Administrator (USFDA). The drug is used in the
treatment of migraine, has an estimated sale of $175 million in 2012 as
per IMS.Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips. or login http://www.epicresearch.co/
No comments:
Post a Comment